Want to see TSE:DHB full AI Analyst Report?
Top Page
Delivra Health Brands
(DHB)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.11
▼(-19.23% Downside)
Action:Reiterated
Date:06/12/26
The score is weighed down primarily by weak financial performance (declining TTM revenue, ongoing net losses, and negative free cash flow) and bearish technical trends (below all key moving averages with negative MACD). Valuation provides limited support because the negative P/E reflects losses and no dividend yield is available.
Positive Factors
Healthy gross margin
A ~45.5% gross margin is a durable structural strength in consumer OTC products: it provides intrinsic product-level profitability and room to cover distribution and marketing. If revenues stabilize, high gross margins support a sustainable path to operating profitability over months.
Negative Factors
Declining revenue trajectory
Material TTM revenue decline (-14.1%) is a lasting operational concern: shrinking top line limits leverage of fixed costs, pressures margins and marketing ROI, and signals distribution or demand weakness. Absent a change in growth drivers, this trend impairs sustainable profitability and scale.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy gross margin
A ~45.5% gross margin is a durable structural strength in consumer OTC products: it provides intrinsic product-level profitability and room to cover distribution and marketing. If revenues stabilize, high gross margins support a sustainable path to operating profitability over months.
Read all positive factors
Delivra Health Brands (DHB) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$3.75M
Dividend YieldN/A
Average Volume (3M)31.36K
Price to Earnings (P/E)―
Beta (1Y)1.71
Revenue Growth-10.74%
EPS Growth-559.18%
CountryCA
Employees22
SectorGeneral
Sector StrengthN/A
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.03
Shares Outstanding31,261,782
10 Day Avg. Volume67,661
30 Day Avg. Volume31,365
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.53Price Target Upside307.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.03
Revenue Forecast (FY)C$10.59M
Delivra Health Brands Business Overview & Revenue Model
Company Description
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's ...
How the Company Makes Money
DHB makes money by generating revenue from the sale of its consumer health and wellness products to customers through its distribution network. Key revenue streams are primarily tied to product sales (e.g., wholesale/retail sell-in and related dis...
Delivra Health Brands Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
53
Neutral
Cash Flow
30
Negative
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.24M | 13.37M | 12.38M | 9.79M | 8.14M | 7.96M |
| Gross Profit | 5.12M | 6.78M | 6.40M | 3.49M | 485.00K | -297.00K |
| EBITDA | -507.00K | 427.00K | 2.35M | 1.40M | -4.25M | -7.04M |
| Net Income | -1.01M | -1.19M | 876.00K | -184.00K | -7.01M | -28.54M |
Balance Sheet | ||||||
| Total Assets | 7.13M | 9.61M | 10.05M | 10.56M | 11.59M | 19.06M |
| Cash, Cash Equivalents and Short-Term Investments | 2.64M | 3.30M | 4.20M | 2.73M | 1.11M | 5.14M |
| Total Debt | 2.33M | 2.11M | 2.03M | 1.96M | 2.11M | 2.16M |
| Total Liabilities | 4.18M | 5.37M | 4.86M | 7.17M | 8.21M | 9.09M |
| Stockholders Equity | 2.94M | 4.24M | 5.19M | 3.39M | 3.37M | 9.98M |
Cash Flow | ||||||
| Free Cash Flow | -325.00K | -754.00K | 756.00K | -1.13M | -4.46M | -9.68M |
| Operating Cash Flow | -325.00K | -754.00K | 756.00K | -1.09M | -4.44M | -9.65M |
| Investing Cash Flow | 0.00 | 0.00 | 11.00K | 2.91M | 1.35M | 12.27M |
| Financing Cash Flow | -17.00K | -36.00K | 594.00K | -255.00K | -309.00K | 446.00K |
Delivra Health Brands Technical Analysis
Positive
0.13
Price Trends
0.10
Positive
0.12
Positive
0.15
Negative
Market Momentum
<0.01
Negative
56.19
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DHB, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.11, above the 50-day MA of 0.10, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.19 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DHB.
Delivra Health Brands Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | C$5.21M | 6.25 | -11.60% | ― | -4.90% | ― | |
44 Neutral | C$5.49M | -1.66 | 43.99% | ― | -2.84% | -228.77% | |
41 Neutral | C$3.75M | -3.86 | -26.42% | ― | -10.74% | -559.18% | |
41 Neutral | C$11.21M | -2.94 | 28.59% | ― | 0.90% | 57.73% |
* General Sector Average
TSE:DHB
Delivra Health Brands
0.13
-0.08
-37.50%
TSE:TGIF
1933 Industries
0.01
0.00
0.00%
TSE:PCLO
PharmaCielo
0.06
0.01
22.22%
TSE:CDVA
CordovaCann
0.04
-0.04
-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.